Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT02304913

Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy

Led by Universität Duisburg-Essen · Updated on 2026-04-14

75

Participants Needed

3

Research Sites

678 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.

CONDITIONS

Official Title

Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Initial treatment with platinum-containing or taxane-based chemotherapy (regardless of the length of the chemotherapy cycle)
  • Diagnosis of senological, gynecological, or internistic tumors
  • Presence of phantogeusia with an average severity of 4 or higher on the numeric rating scale
  • Willingness to participate and provide written informed consent
Not Eligible

You will not qualify if you...

  • Severe stomatitis
  • Dysgeusia before chemotherapy caused by neurological diseases, diabetes, or drugs with taste disorder side effects
  • Low white blood cell counts (leucopenia/neutropenia)
  • Use of anticoagulant medications
  • Smoking
  • Severe physical or mental conditions preventing study participation
  • Participation in other complementary and alternative medicine treatments within integrative oncology care
  • Participation in other studies on treatments for oral complications

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Department of Gynecology & Gynecologic Oncology, Evang. Kliniken Essen-Mitte

Essen, North Rhine-Westphalia, Germany, 45136

Active, Not Recruiting

2

Universitätsklinikum Mannheim, Internistische Onkologie

Mannheim, Germany, 68167

Actively Recruiting

3

Robert Bosch Krankenhaus Stuttgart

Stuttgart, Germany, 70376

Not Yet Recruiting

Loading map...

Research Team

H

Heidemarie Haller, PhD

CONTACT

H

Holger Cramer, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here